===يتم ترجمة المعلومات التالية بواسطة الكمبيوتر ، يرجى الاتصال بالناشر
===ASP9521 is a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3). ASP9521 has demonstrated anti-tumour activity in in vitro and in vivo preclinical models. ASP9521 inhibited conversion of androstenedione (AD) into testosterone (T) by recombinant human or cynomolgus monkey AKR1C3 in a concentration-dependent manner. https://www.bocsci.com/asp-9521-cas-1126084-37-4-item-462669.html
يرجى الاتصال بالناشر وتحتاج إلى مساعدة: admin@b2bgood.com